
GSK makes strong start to 2025 with growth in sales, profits and earnings
Emma Walmsley, Chief Executive Officer, GSK: "GSK continues to make strong progress, demonstrating the quality, strength and resilience of our portfolio. Specialty Medicines, our largest business, delivered strong sales contributions in the quarter …